# DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences

- Source: PR Newswire M&A
- Published: 2026-11-03T19:53:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/drug-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-bright-minds-biosciences-302928125.html
- Canonical: https://groundlevelnews.com/story/drug-shareholder-investigation-suewallst-notifies-investors-of-potenti-99a9df/

Investors who lost money when DRUG shares sold off on the FDA's partial clinical hold for the planned Phase 2 BMB-101 epilepsy trial may have the right to seek recovery, even if they have already sold. NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Shareholders of Bright Minds Biosciences...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._